Truncating Variant Prevalence Up in Peripartum Cardiomyopathy

This article originally appeared here.
Share this content:
Truncating Variant Prevalence Up in Peripartum Cardiomyopathy
Truncating Variant Prevalence Up in Peripartum Cardiomyopathy

FRIDAY, Jan. 8, 2016 (HealthDay News) -- Women with peripartum cardiomyopathy have a prevalence of truncating variants similar to that seen in patients with dilated cardiomyopathy, according to a study published online Jan. 6 in the New England Journal of Medicine.

James S. Ware, Ph.D., from Harvard Medical School in Boston, and colleagues sequenced 43 genes with variants that have been associated with dilated cardiomyopathy in 172 women with peripartum cardiomyopathy. The authors compared the prevalence of different variant types in these women with the prevalence in individuals with dilated cardiomyopathy, and with population controls.

Among the women with peripartum cardiomyopathy, the researchers identified 26 distinct, rare truncating variants in eight genes. The prevalence of truncated variants was similar to that seen in patients with dilated cardiomyopathy (15 versus 17 percent; P = 0.81), and was significantly higher than that seen in the reference population (15 versus 4.7 percent; P = 1.3 × 10−7). Two-thirds of truncating variants were identified in TTN; almost all were located in the titin A-band. Seven of the variants had been reported in patients with idiopathic dilated cardiomyopathy. The presence of TTN truncating variants correlated with lower ejection fraction at one-year follow-up in a cohort of 83 women with peripartum cardiomyopathy (P = 0.005).

"The distribution of truncating variants in a large series of women with peripartum cardiomyopathy was remarkably similar to that found in patients with idiopathic dilated cardiomyopathy," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »